TOP 10 QUOTES FROM TOBI 2018 - Catalyst Regenerative Network
16082
post-template-default,single,single-post,postid-16082,single-format-standard,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
TOP 10 TALKS FROM TOBI 2018

TOP 10 QUOTES FROM TOBI 2018

It’s always exciting at The Orthobiologic Institute’s (TOBI) annual event and the 2018 Symposium was no different. Expert thought leaders presented compelling research and advancements that can benefit everyone in the regenerative medicine space. We put together the top 10 quotes from a few of this year’s featured speakers who are at the forefront of the regenerative charge.

10. “Cell-based therapies, outside of spine, will remain dominated by autologous systems.” – Robin R. Young, Orthopedics This Week & PearlDiver Technologies (Wayne, PA)

9. “The amount of GH, hormonal balance, Thyroid function, Androgens, sleep quality and life habits (alcohol and tobacco) have a straight correlation with the quality of PRP.” – José Fábio Lana, MD, The Bone and Cartilage Institute (Indaiatuba, São Paulo, BRAZIL)

8. “Most regenerative medicine projects are in long term development projects.” – Robin R. Young, Orthopedics This Week & PearlDiver Technologies (Wayne, PA)

7. “Activated platelets are critical to recruiting stem cells.” – José Fábio Lana, MD, The Bone and Cartilage Institute (Indaiatuba, São Paulo, BRAZIL)

6. “As of Q1 2018, there are 959 gene and cellular therapy clinical trials underway worldwide according to the Alliance for Regenerative Medicine.” – Robin R. Young, Orthopedics This Week & PearlDiver Technologies (Wayne, PA)

5. “With healthcare costs rising and healthcare value being emphasized, pysicians now, more than ever, must capture and track patient care outcomes.” – Kwadwo Boachie-Adjei, Regenerative SportsCare Institute (New York, NY)

4. “Efficacy of the Platelet Product depends upon the concentration and composition of the releasate components at the site of application.” – José Fábio Lana, MD, The Bone and Cartilage Institute (Indaiatuba, São Paulo, BRAZIL)

3. “We have [biomarkers] that can indicate early matrix degradation in knees at risk for OA and that respond to early treatment approaches.” – Christian Lattermann, MD, University of Kentucky School of Medicine (Lexington, KY)

2. “Optimal concentration of a Platelet-Rich Plasma for angiogenesis is 1.5 – 3.0 million/uL platelets.” – José Fábio Lana, MD, The Bone and Cartilage Institute (Indaiatuba, São Paulo, BRAZIL)

1. “Innovation is necessary for continued advancements in healthcare.” – Freddie H. Fu, MD, University of Pittsburg School of Medicine, Department of Orthopedic Surgery (Pittsburgh, PA)